Keyphrases
Antigen Dose
100%
Cellular Immune Response
25%
Clinical Trials
12%
Domain-independent
100%
Emerging Infectious Diseases
12%
Humoral Immune Response
25%
Immune Response
12%
MF59
12%
MF59 Adjuvant
12%
Middle East Respiratory Syndrome
100%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Neutralizing Antibodies
37%
Optimal Dose
12%
Pseudotype
12%
Public Health
12%
Receptor-binding Domain
37%
Recombinant Protein
12%
Subunit Vaccine
100%
Vaccine Candidate
12%
Vaccine Trial
12%
Immunology and Microbiology
Adjuvant
12%
Adoptive Immunity
25%
Antibody Response
12%
Humoral Immunity
25%
Immune Response
12%
Infection
25%
Infectious Disease
12%
MF59
25%
Middle East Respiratory Syndrome
100%
Middle East Respiratory Syndrome Coronavirus
100%
Neutralizing Antibody
37%
Optimal Drug Dose
12%
Receptor Binding
37%
Subunit Vaccine
100%